secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuvation Bio Inc. (NUVB)
CIK:        0001811063
Form:       8-K
Filed at:   2023-05-16T23:59:59+00:00
Accession:  0001193125-23-146073
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Nuvation Bio annual meeting: directors elected, KPMG ratified, 20% opposed exec pay
--------------------------------------------------------------------------------

- Director Robert B. Bazemore Jr. re-elected with 140.6M for, 50.1M withheld (26% of votes cast).
- Kim Blickenstaff re-elected as Class B director with 1M for, none withheld.
- KPMG LLP ratified as auditor for FY2023 with 206.3M for, 0.1M against, 0.3M abstain.
- Advisory vote on executive compensation passed 153.7M for, 38.0M against (20% disapproval).
- Total shares represented 94% of Class A and 100% of Class B common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811063/000119312523146073/0001193125-23-146073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811063/000119312523146073/d420969d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-146073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer